Skip to main content
. 2021 Mar 2;7:22. doi: 10.1038/s41523-021-00229-5

Table 3.

Relapse-free survival in metastatic setting.

Parameter Hazards ratio (95% CI) Submodel p value False discovery rate
No treatment 1.00
A—ivermectin only 1.48 (0.41–5.39)
B—anti-PD1 only 0.75 (0.21–2.72)
Beyond product of A + B 0.02 (0–0.16) <0.001 <1%
Adding IL-2 to A + B 0.58 (0.05–6.18) 0.64 (73%)